Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Domain Raises a $500M VC Fund, Dissident Prods Amylin Again, Avanir Passes Pivotal Test, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
08/13/09 |
San Diego
|
|
Vertex Drug Could Be “Man on the Moon” for Cystic Fibrosis Therapy, Says Researcher Bonnie Ramsey
|
Luke Timmerman |
08/07/09 |
National
|
|
Cash Running Low at Altus Pharma
|
Ryan McBride |
08/05/09 |
Boston
|
|
Pulmatrix, With One Drug for Multiple Bugs, Aims to Fundamentally Change Flu Treatment
|
Luke Timmerman |
06/09/09 |
Boston
|
|
Alnara Pharma Completes Key Cystic Fibrosis Drug Trial, “Extremely Encouraged” by Results
|
Ryan McBride |
05/28/09 |
Boston
|
|
Vertex Starts Pivotal CF Trials
|
Luke Timmerman |
05/27/09 |
Boston
|
|
Obama Stimulates UW, Public Biotechs Run Low on Cash, Healionics Ships Glaucoma Product & More Seattle-Area Life Sciences News
|
Luke Timmerman |
03/26/09 |
Seattle
|
|
Sticking to its Guns with Gene Therapy, Genzyme To Present Key Findings Within Days
|
Luke Timmerman |
03/25/09 |
Boston
|
|
Alnara Leapfrogs Into Phase III, Just Six Months After Getting Started
|
Ryan McBride |
03/25/09 |
Boston
|
|
EU Spurns Gilead’s Aztreonam
|
Luke Timmerman |
03/20/09 |
Seattle
|
|
Epix Reaches Milestone in CF Research
|
Ryan McBride |
03/11/09 |
Boston
|
|
Early Histogen Study Offers Hope for Retreating Hairlines, Cadence Pharmaceuticals and Vertex Raise Lots of Cash, Unmanned Predator Begins New Air Patrol, & More San Diego BizTech News
|
Bruce V. Bigelow |
02/23/09 |
San Diego
|
|
Out With Hedge Funds, In With Blue Bloods: Vertex Transforms Investor Base Via Stock Sale
|
Luke Timmerman |
02/20/09 |
Boston
|
|
Vertex Raises $320M in Secondary Stock Offering
|
Luke Timmerman |
02/19/09 |
Boston
|
|
Mpex Pharma Lands $27.5M in Fourth Round
|
Ryan McBride |
02/10/09 |
San Diego
|
|
Vertex CEO Josh Boger Retiring In May; Matthew Emmens To Fill Role
|
Luke Timmerman |
02/05/09 |
Boston
|
|
Altus Cuts 75 Percent of Staff
|
Luke Timmerman |
01/26/09 |
Boston
|
|
KaloBios Gets $12M Genzyme, Baxter
|
Luke Timmerman |
12/22/08 |
Boston
|
|
Luck, Curiosity, Naivete: The Essential Ingredients of Innovation
|
Luke Timmerman |
12/16/08 |
Seattle
|
|
Economy Makes Disease Foundations Get Choosier
|
Ryan McBride |
12/15/08 |
Boston
|
|
Sequenom May Spot Single-Gene Birth Defects, like Cystic Fibrosis, in a Sample of Mother’s Blood
|
Luke Timmerman |
11/24/08 |
San Diego
|
|
Simple DNA Test Spots Deadly MRSA Bacteria; Adnavance Aims To Take It Mainstream
|
Luke Timmerman |
11/10/08 |
San Diego
|
|
Vertex Cystic Fibrosis Drug Improves Breathing for 28 Days
|
Luke Timmerman |
10/20/08 |
Boston
|
|
Pulmatrix, Emerging From Stealth Mode, Makes Aerosols to Kill Flu and Bacterial Bugs in the Lungs
|
Luke Timmerman |
09/18/08 |
Boston
|
|
Gilead Drug For Cystic Fibrosis Fails to Win FDA Approval
|
Luke Timmerman |
09/16/08 |
Seattle
|
|
Gilead’s Seattle Crew Awaits FDA Clearance of Cystic Fibrosis Drug, Catalyst for Future Growth
|
Luke Timmerman |
09/15/08 |
Seattle
|
|
Alnylam Sees Opportunity in Turning Genes On, And Off
|
Luke Timmerman |
09/05/08 |
Boston
|
|
Vertex Marching Ahead With Cystic Fibrosis Program
|
Luke Timmerman |
08/01/08 |
Boston
|
|
Genzyme, PTC Therapeutics Form Collaboration on Drug For Genetic Diseases
|
Luke Timmerman |
07/17/08 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
